Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 1997

View Archived Issues

Company Profile: Inhale Therapeutic Systems

Immunological method for preventing ALL in children available for licensing

NIH seeks licensees for raf protein kinase therapeutics

Brain GABA-A receptor ligands prepared at Neurogen

Bristol-Myers Squibb develops new ET antagonists

Anticonvulsants with reduced side effects from RCT

VEGF inhibitors discovered by Zeneca

New renin inhibitor in preclinical testing at JT/Yoshitomi

Novartis claims new antiasthmatic agents

Inhibitors of viral neuraminidase from Biota

American Home Products reports compounds for atherosclerosis

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

BMS to sell Gea

Clinical results reported for Onco TCS

New guidelines for patients exposed to fenfluramine or dexfenfluramine

FACET study demonstrates improved asthma control with Pulmicort and Oxis

D-19575: new cytostatic drug without renal side effects

Anesta's Actiq denied FDA approval

Development of tolerance to OPC-31260 effects in rats after chronic treatment

Roche launches Fortovase in U.S.

P&G kicks off U.S. arm of ALIVE trial

S-Nitrosocaptopril exerts both acute and chronic hypotensive effects in rats

Roche resubmits NDA for Xenical

Results reported for Myriad's CardiaRisk

Cardioprotective activity of monoHER demonstrated in preclinical models

Celecoxib: safety and efficacy data presented at rheumatology meeting

Novartis submits BLA for Simulect in U.S.

Amylin Pharmaceuticals: Q3 1997 highlights

New antidepressant and cognition enhancer developed in Russia

Biomira and Intracel negotiate acquisition of certain Biomira assets

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...